Page 52 - 35-1
P. 52

The Financial Statement Comparability of Listed Foreign Firms in Taiwan: The Effect of Board Interlocks and
               Financial Statement Fraud



                                                 3. Findings


                    This study finds that overall, the financial statement comparability of KY companies
               is worse than that of non-KY companies, and non-KY companies having board interlocks

               with KY companies display poorer comparability than those without interlocks. These
               findings indicate that the characteristics of KY companies (high organizational complexity
               and overseas operations causing audit difficulties) affect their financial statement
               comparability, and that non-KY companies having board interlocks with KY companies

               also suffer negative impacts on their financial statement comparability through the
               interlocks. After the case of Pharmally, the financial statement comparability has improved
               for all non-KY companies regardless of board interlocks with KY companies. However,
               the financial statement comparability for KY companies does not improve. Instead, it

               shows signs of deterioration compared to non-KY companies. One possible reason is
               that the fraud case coincided with the COVID-19 pandemic, restricting auditors from
               conducting on-site audits of KY companies with overseas operations. This finding suggests
               during the pandemic, the location of company operations is a significant factor affecting

               financial statement comparability.


                                 4. Research Limitations/Implications



                    The primary limitation of this study lies in the timing of the Pharmally Case, which
               occurred in August 2020. To calculate comparability after the case of Pharmally using
               a complete set of 16 quarters of data, it would be necessary to collect data through
               September 2024 to obtain the first complete comparability measure based on 16 quarters.

               Unfortunately, as of the final revision, we were still unable to obtain the complete data for
               Q3 2024. Due to an insufficient data period, we cannot use the 16 quarters of data as used
               in Hypotheses 1 and 2 to calculate the financial statement comparability for Hypotheses 3
               to 5. We have to calculate the comparability using data from the first two quarters instead.
               However, De Franco et al. (2011) notes when results using different periods align with the

               main results calculated using 16 quarters, this limitation should not cause bias. Still, due
               to the short post-incident period (only five quarters), we do not observe any significant
               difference before and after the fraud case. Future studies with more post-incident data may



                                                      44
   47   48   49   50   51   52   53   54   55   56   57